| Lizenz: Creative Commons Namensnennung 4.0 International PDF - Veröffentlichte Version (7MB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-433666
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.43366
Zusammenfassung
Poor drug availability in the tissue of interest is a frequent cause of therapy failure. While nanotechnology has developed a plethora of nanocarriers for drug transport, their ability to unequivocally identify cells of interest remains moderate. Viruses are the ideal nanosized carriers as they are able to address their embedded nucleic acids with high specificity to their host cells. Here, it is ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags
Downloadstatistik